Decoy Therapeutics Inc.
DCOY
$5.15
-$0.29-5.33%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -51.73% | -1.87% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -42.29% | -7.30% | |||
| Operating Income | 42.29% | 7.30% | |||
| Income Before Tax | -927.78% | 8.80% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -927.78% | 8.80% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -927.78% | 8.80% | |||
| EBIT | 42.29% | 7.30% | |||
| EBITDA | 42.64% | 7.31% | |||
| EPS Basic | -412.14% | 0.00% | |||
| Normalized Basic EPS | -- | -- | |||
| EPS Diluted | -412.14% | 0.00% | |||
| Normalized Diluted EPS | -- | -- | |||
| Average Basic Shares Outstanding | -- | -- | |||
| Average Diluted Shares Outstanding | 19.74% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||